Home > Business > Industry

Ginseng shown to inhibit colorectal cancer growth in mice

Published: 28 Oct. 2024, 18:51 Updated: 28 Oct. 2024, 19:52

CHO YONG-JUN
[email protected]

University of Michigan Professor Narayanan Parameswaran speaks at the International Conference on Ginseng, which takes place in Jeju Island from Sunday to Wednesday. [KOREAN SOCIETY OF GINSENG]

A group of Korean and Chinese researchers found that ginseng can inhibit the growth of colorectal cancer cells in a study on mice, which was announced at an academic conference hosted by the Korean Society of Ginseng.

The research paper, led by Kyungpook National University Professors Kim Myoung-ok and Ryoo Zae-young, discovered that ginsenoside Rh2 "exerts anticancer activity" by "suppressing the Axl signaling pathway" through experiments on mice.

“It is expected that our research results can help develop a new type of anticancer drug that reduces side effects and focuses more on the treatment of the cancer source,” the team said.

Ginsenoside Rh2 is a bioactive compound extracted from ginseng.

Another research paper, led by University of Michigan Professor Narayanan Parameswaran, found that red ginseng extract treatment prevented dysbiosis-induced bone loss in mice after the consumption of antibiotics.

These research findings were shared at the International Conference on Ginseng, which takes place in Jeju from Oct. 27 to 30.

BY CHO YONG-JUN [[email protected]]